These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1233215)

  • 1. Haemodynamic effects of intravenous disopyramide in heart failure.
    Jensen G; Sigurd B; Uhrenholt A
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):167-73. PubMed ID: 1233215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic and electrocardiographic effects of intravenous disopyramide (rythmodan) following acute myocardial infarction.
    Davies GJ; Marrott PK; Muir JR
    Br J Clin Pharmacol; 1979 Feb; 7(2):183-7. PubMed ID: 760751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.
    Leach AJ; Brown JE; Armstrong PW
    Am J Med; 1980 Jun; 68(6):839-44. PubMed ID: 7386491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of intravenous disopyramide on the hemodynamics of patients hospitalized in intensive care units].
    Boland J; Lisin N; Marcelle R; Carlier J
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):145-51. PubMed ID: 1015909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulatory effects of intravenous disopyramide in heart failure.
    Jensen G; Uhrenholt A
    J Int Med Res; 1976; 4(1 Suppl):42-5. PubMed ID: 1026527
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1976; 199(1-2):41-51. PubMed ID: 1251772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous disopyramide in myocardial infarction: a haemodynamic study.
    Marrott PK; Nairn PL; Hill PD; Turner G; Sharman J
    N Z Med J; 1983 Jan; 96(723):4-7. PubMed ID: 6571755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of acute haemodynamic effects of nifedipine and isosorbide dinitrate in patients with heart failure following acute myocardial infarction.
    Cantelli I; Pavesi PC; Naccarella F; Bracchetti D
    Int J Cardiol; 1981; 1(2):151-63. PubMed ID: 7338418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemodynamics of intravenous disopyramide.
    Sutton R
    J Int Med Res; 1976; 4(1 Suppl):46-8. PubMed ID: 1026528
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous disopyramide in acute myocardial infarction: a haemodynamic and pharmacokinetic study.
    Cameron J; Stafford W; Pritchard D; Norris R; Ravenscroft P
    J Cardiovasc Pharmacol; 1984; 6(1):126-31. PubMed ID: 6199595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of disopyramide at rest and during exercise in normal subjects.
    Thadani U; Manyari D; Gregor P; Olowoyeye J; Leach A; West RO; Parker JO
    Cathet Cardiovasc Diagn; 1981; 7(1):27-34. PubMed ID: 7214518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse hemodynamic effects of intravenous disopyramide compared with quinidine in conscious dogs.
    Walsh RA; Horwitz LD
    Circulation; 1979 Nov; 60(5):1053-8. PubMed ID: 487539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide.
    Beltrame J; Aylward PE; McRitchie RJ; Chalmers JP
    J Cardiovasc Pharmacol; 1984; 6(3):483-90. PubMed ID: 6202976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy.
    Kimball BP; Bui S; Wigle ED
    Am Heart J; 1993 Jun; 125(6):1691-7. PubMed ID: 8498312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of disopyramide in patients after open-heart surgery.
    Naqvi N; Thompson DS; Morgan WE; Williams BT; Coltart DJ
    Br Heart J; 1979 Nov; 42(5):587-94. PubMed ID: 316334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute haemodynamic effects of urapidil in patients with chronic left ventricular failure.
    Tebbe U; Wurst W; Neuhaus KL
    Eur J Clin Pharmacol; 1988; 35(3):305-8. PubMed ID: 3181283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of disopyramide of left ventricular function: an echocardiographic study of the extent and time course (author's transl)].
    Angermann C; Autenrieth G
    Klin Wochenschr; 1981 Jul; 59(14):803-11. PubMed ID: 7265814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of intravenous diltiazem with impaired left ventricular function.
    Materne P; Legrand V; Vandormael M; Collignon P; Kulbertus HE
    Am J Cardiol; 1984 Oct; 54(7):733-7. PubMed ID: 6486022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the acute electrophysiological and cardiovascular action of disopyramide in man.
    Marrott PK; Ruttley MS; Winterbottam JT; Muir JR
    Eur J Cardiol; 1976 Sep; 4(3):303-12. PubMed ID: 964279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.